Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioAtla, Inc.

0.4730
+0.02505.58%
Post-market: 0.4700-0.0030-0.63%16:10 EDT
Volume:538.91K
Turnover:244.60K
Market Cap:27.62M
PE:-0.33
High:0.4780
Open:0.4780
Low:0.4362
Close:0.4480
Loading ...

BRIEF-Bioatla Inc - Announces 30% Workforce Reduction

Reuters
·
28 Mar

BioAtla Q4 Net Loss $14.9M

Benzinga
·
28 Mar

Bioatla Inc - Announces 30% Workforce Reduction

THOMSON REUTERS
·
28 Mar

BRIEF-BioAtla Q4 Net Income USD -14.884 Million

Reuters
·
28 Mar

Bioatla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

THOMSON REUTERS
·
28 Mar

Press Release: BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress

Dow Jones
·
28 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
27 Mar

Bioatla Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
26 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
24 Mar

Bioatla Inc expected to post a loss of 38 cents a share - Earnings Preview

Reuters
·
21 Mar

BioAtla Announces Two Poster Presentations at Upcoming Medical Meetings

GlobeNewswire
·
20 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
20 Mar

Bioatla to Announce Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Highlights on March 27, 2025

THOMSON REUTERS
·
19 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
17 Mar

BioAtla Awards Executive Bonuses and Stock Units

TIPRANKS
·
15 Mar

BioAtla (BCAB) Upgraded to Buy: Here's What You Should Know

Zacks
·
03 Jan

BioAtla Secures $9.2M for Clinical Program Advancements

TIPRANKS
·
21 Dec 2024

BioAtla Prices Registered Direct Offering of 9.7 Million Shares for Expected Gross Proceeds of $9.2 Million

MT Newswires Live
·
20 Dec 2024

BioAtla Highlights Advancements in CAB Cancer Therapy

TIPRANKS
·
20 Dec 2024

BioAtla to sell 9.68M shares at 95.2c in registered direct offering

TIPRANKS
·
20 Dec 2024